Education
About Us
Working with TipRanks
Follow Us
Patrick Mahaffy Insider Profile
4 Followers
Patrick Mahaffy, President & CEO, Director at Clovis Oncology, holds 970.79K shares in Clovis Oncology (Ticker: CLVSQ), holds 0.00 shares in Orexigen (Ticker: OREXQ), holds 0.00 shares in Flexion Therapeutics (Ticker: FLXN). Most recently, Patrick Mahaffy Bought ― shares of Clovis Oncology on Aug 19, 2019 for an estimated value of 279.58K.
Patrick Mahaffy Clovis Oncology (CLVSQ)President & CEO, Director
Clovis Oncology (CLVSQ)
President & CEO, Director
Not Ranked
Patrick Mahaffy has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Patrick Mahaffy does not currently own shares as a corporate insider.
A breakdown of Patrick Mahaffy's holdings
Insider Roles
Patrick Mahaffy does not currently hold a role as a corporate insider.
Roles that Patrick Mahaffy holds in companies
Most Profitable Insider Trade
Stock:
Clovis Oncology
(CLVSQ)
(CLVSQ)
Rating:Informative Buy
Date:Aug 19, 2019 - Aug 19, 2020
Return:-8.10%
The most profitable trade made by Patrick Mahaffy
Patrick Mahaffy's Trading History
Clovis Oncology
Aug 19, 2019
―
Informative Buy
279.58K
$14.56K
Orexigen
―
―
―
$0.00
Flexion Therapeutics
Nov 19, 2021
―
Uninformative Sell
338.50K
$0.00
List of latest transactions for each holding click on a transaction to see Patrick Mahaffy's performance on stock
You May Also Like
Patrick Mahaffy insider profile FAQ
What is the percentage of profitable transactions made by Patrick Mahaffy?
The percentage of profitable transactions made by Patrick Mahaffy is ―.
What is the average return per transaction made by Patrick Mahaffy?
The average return per transaction made by Patrick Mahaffy is ―.
What stocks does Patrick Mahaffy hold?
Patrick Mahaffy holds: CLVSQ, OREXQ, FLXN stocks.
What was Patrick Mahaffy’s latest transaction?
Patrick Mahaffy latest transaction was an Informative Buy of $279.58K.
What was Patrick Mahaffy's most profitable transaction?
Patrick Mahaffy’s most profitable transaction was an Informative Buy of CLVSQ stock on August 19, 2019. The return on the trade was -8.10%.
What is Patrick Mahaffy's role in Clovis Oncology?
Patrick Mahaffy's role in Clovis Oncology is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.